Titan Biotech Ltd.
| BSE: 524717 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE150C01011 |
| BSE 10:34 | 01 Jul | 222.10 |
-4.45 (-1.96%) |
OPEN
229.40 |
HIGH
229.40 |
LOW
222.10 |
| NSE 05:30 | 01 Jan | Titan Biotech Ltd |
| OPEN | 229.40 |
| PREVIOUS CLOSE | 226.55 |
| VOLUME | 694 |
| 52-Week high | 423.60 |
| 52-Week low | 205.40 |
| P/E | 8.46 |
| Mkt Cap.(Rs cr) | 183 |
| Buy Price | 222.35 |
| Buy Qty | 32.00 |
| Sell Price | 225.00 |
| Sell Qty | 56.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 830.95 | 0.02 | 966.90 | 664.10 | 199369.83 |
| Divi's Lab. | 3617.95 | -0.36 | 5425.00 | 3365.10 | 96038.48 |
| Cipla | 929.90 | 1.61 | 1083.15 | 850.00 | 75033.63 |
| Dr Reddy's Labs | 4347.85 | -1.18 | 5613.65 | 3655.00 | 72365.62 |
| Apollo Hospitals | 3643.85 | -0.98 | 5930.70 | 3365.90 | 52391.27 |
| Torrent Pharma. | 2856.15 | -0.11 | 3304.45 | 2485.00 | 48331.77 |
| Gland Pharma | 2676.25 | -0.95 | 4350.00 | 2498.00 | 44077.84 |
| Abbott India | 18694.60 | -0.49 | 23902.30 | 15525.00 | 39726.02 |
| Piramal Enterp. | 1636.50 | -1.34 | 3013.00 | 1561.00 | 39055.07 |
| Biocon | 306.80 | -0.37 | 414.30 | 305.00 | 36834.41 |
| Zydus Lifesci. | 357.10 | 0.10 | 655.00 | 319.40 | 36556.33 |
| Alkem Lab | 3000.00 | -0.03 | 4067.70 | 2835.00 | 35865.00 |
| Max Healthcare | 362.75 | -1.35 | 472.60 | 251.00 | 35173.33 |
| Aurobindo Pharma | 514.60 | 0.16 | 1012.90 | 503.40 | 30150.41 |
| Lupin | 612.05 | 0.11 | 1193.00 | 583.05 | 27823.79 |
| Glaxosmi. Pharma | 1509.40 | 0.65 | 1917.00 | 1433.05 | 25570.75 |
| Laurus Labs | 462.45 | -0.44 | 723.55 | 433.20 | 24849.75 |
| Ipca Labs. | 902.60 | 1.19 | 1383.55 | 831.40 | 22898.96 |
| Syngene Intl. | 547.35 | -1.62 | 699.95 | 508.10 | 21972.27 |
| Pfizer | 4080.00 | -0.19 | 6164.80 | 4056.00 | 18666.00 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
